Klacid Saft Forte (Clarithromycin)

Clarithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing translocation of the peptidyl‑tRNA. This blocks the formation of essential proteins, halting bacterial growth (bacteriostatic) and, at higher concentrations, killing the bacteria (bactericidal). The mechanism provides activity against a broad spectrum of Gram‑positive, some Gram‑negative and atypical organisms.

The prescribed dose of Klacid Saft Forte is determined by the treating clinician based on the type and severity of the infection, the patient’s age, weight, renal and hepatic function, and any concomitant medications. Dosage adjustments may be required for special populations, and the prescriber will provide specific instructions.

Clarithromycin is classified as Pregnancy Category B, indicating that animal studies have not shown risk to the fetus and there are no adequate human studies. It may be used during pregnancy only if the potential benefit justifies the potential risk. Clarithromycin passes into breast milk in small amounts; breastfeeding decisions should be made in consultation with a healthcare provider.

To order Klacid Saft Forte, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After submission, the sales team will verify trade or institutional credentials, then respond with pricing, availability, shipping details (including any cold‑chain requirements), and required import documentation.

Clarithromycin is often compared with azithromycin, another macrolide. Both share a similar mechanism of inhibiting protein synthesis, but azithromycin has a longer half‑life, allowing once‑daily dosing and shorter treatment courses. Clarithromycin generally achieves higher tissue concentrations and may be preferred for certain infections, while azithromycin is favored for its convenient dosing and lower drug‑interaction potential.

Klacid Saft Forte should be stored at ambient temperature below 25 °C. Keep the oral solution in its original container, protect it from moisture and direct light, and ensure the cap is tightly closed. Do not freeze the product. If the solution appears discolored or contains particles, discard it.

Klacid Saft Forte is taken orally as a measured syrup. The dose is measured with a calibrated dosing device (e.g., oral syringe or cup) provided with the product. It may be taken with or without food, unless the prescriber advises otherwise. Patients should follow the exact dosing schedule prescribed and complete the full course of therapy.

Serious adverse reactions include severe allergic responses such as anaphylaxis or Stevens‑Johnson syndrome, QT interval prolongation that can lead to cardiac arrhythmias, and Clostridioides difficile‑associated colitis, which may cause life‑threatening diarrhea. Patients should seek immediate medical attention if they experience rash, fever, persistent vomiting, palpitations, or severe diarrhea.

Klacid Saft Forte is contraindicated in individuals with a known hypersensitivity to clarithromycin, other macrolide antibiotics, or any component of the formulation. It should also be avoided in patients taking medications that can cause serious cardiac arrhythmias when combined with clarithromycin, such as cisapride or domperidone, unless the prescriber determines the benefits outweigh the risks.